newsfilter
← Latest News
PR Newswire·

Vanda Pharmaceuticals Provides Regulatory Update on Tradipitant for Motion Sickness

Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA), today announced the following updates regarding tradipitant for motion sickness: Partial Clinical...